A plain-language comparison of BPC-157 and GHK-Cu: structure, size, the pathways each is studied through, the research areas each belongs to, and what neither has been tested for in people.
A plain-language look at what published BPC-157 tendon studies actually report, which of them used cells or animals, and what the research still does not show.
What the published record actually reports about BPC-157 safety: no Phase II or III human efficacy trial, small pilot infusion references, and open questions.
What published research says about BPC-157 and pain: a 2026 review of pain-signal mechanisms, the animal-model context, and the limits of the evidence.
What published research says about BPC-157 and muscle: a 2022 review across three muscle types, 2025 rat reattachment models, and what the animal evidence cannot answer.
What published research says about BPC-157 and ligaments: the 2010 rat MCL study, a 2026 mechanism review, and what the animal evidence does and does not show.
A plain-language look at what published animal research has studied about BPC-157 and the heart: bleeding, clotting, heart rhythm, and the aortic wall.
BPC-157 comes from a protein in human gastric juice. Plain-language look at the rat and tissue studies on the digestive tract, and what they do not show.
Published eye research on BPC-157 rests mainly on one 2023 review of glaucoma and other animal models. Here is what it covers, and what it does not.
What published research says about BPC-157 and the brain: one 2021 animal-model review, a 2026 pain-pathway review, and an honest look at how thin that record is.










